drugset / Trial / NCT01593072
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of healthy male and female subjects with intravenous (IV) infusions of AVI 7537 compared to matched placebo in and to evaluate the pharmacokinetics (PK).
Timeline
- Start
- 2012-08
- Primary completion
- 2013-01
- Completion
- 2013-01
Outcome
Outcome not reported
Stopped (Business): “Terminated for convenience of the Government due to funding constraits”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AVI-7537 | Unknown | 4.5 mg/kg | Intravenous |
| Comparator | AVI-7537 | Unknown | 9 mg/kg | Intravenous |
| Comparator | AVI-7537 | Unknown | 15 mg/kg | Intravenous |
| Comparator | AVI-7537 | Unknown | 30 mg/kg | Intravenous |